TipRanks
Advertisement
Advertisement
Cutia Therapeutics Sets Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany AnnouncementsCutia Therapeutics Sets Board Meeting to Approve Interim Results and Consider Dividend
2M ago
Cutia Therapeutics Wins Shareholder Backing for All AGM Resolutions
Premium
Company Announcements
Cutia Therapeutics Wins Shareholder Backing for All AGM Resolutions
3M ago
Cutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio
Premium
Company Announcements
Cutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio
5M ago
Cutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
PremiumCompany AnnouncementsCutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
7M ago
Cutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Cutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
7M ago
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
Premium
Company Announcements
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
9M ago
Cutia Therapeutics Completes HK$240 Million Share Placement
PremiumCompany AnnouncementsCutia Therapeutics Completes HK$240 Million Share Placement
1y ago
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
Premium
Company Announcements
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
1y ago
Cutia Therapeutics Announces Board Changes
Premium
Company Announcements
Cutia Therapeutics Announces Board Changes
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―